First Product in the UK Market... Anticipating a First-Mover Advantage
Celltrion Receives UK Approval for Asthma Drug Biosimilar 'Xolair'
Celltrion has announced that their biosimilar Omvoh (CT-P39), a treatment for allergic asthma and chronic idiopathic urticaria, has been approved by the UK's Medicines and Healthcare products…